5Y Capital logo

5Y Capital

Asia, Shanghai, China, Xuhui

Description

5Y Capital is a firm engaged in providing early-stage venture investments.

Investor Profile

5Y Capital has made 103 investments, with 5 in the past 12 months and 22% as lead.

Stage Focus

  • Series C (24%)
  • Series A (21%)
  • Series B (21%)
  • Seed (10%)
  • Series D (7%)
  • Series E (6%)
  • Series Unknown (4%)
  • Angel (3%)
  • Series F (2%)
  • Corporate Round (1%)

Country Focus

  • China (69%)
  • United States (22%)
  • India (4%)
  • United Kingdom (2%)
  • Hong Kong (1%)
  • Brazil (1%)
  • Singapore (1%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Internet
  • Software
  • Biotechnology
  • Information Technology
  • Health Care
  • Saas
  • Automotive
  • Apps
  • Autonomous Vehicles
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 5Y Capital frequently co-invest with?

Shunwei Capital
Asia, Beijing, China, Beijing
Co-Investments: 8
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 14
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 9
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 10
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 10
BAI capital
Asia, Beijing, China, Beijing
Co-Investments: 8
DCM Ventures
North America, California, United States, Menlo Park
Co-Investments: 14
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 14
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 8
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 21

Which angels does 5Y Capital often collaborate with?

BG
Asia, China
Shared Deals: 1
SG
North America, California, United States, San Francisco
Shared Deals: 1
EY
North America, California, United States, San Francisco
Shared Deals: 1
Gan Jie
Asia, Beijing, China
Shared Deals: 1
HB
North America, New York, United States, New York
Shared Deals: 1
Xiaopeng He
Asia, Guangdong, China, Guangzhou
Shared Deals: 1
TW
North America, New York, United States, New York
Shared Deals: 1
Adrian Cheng
Asia, Hong Kong
Shared Deals: 1
Li Zexiang
Asia, Hong Kong
Shared Deals: 1

What are some of recent deals done by 5Y Capital?

D-Robotics is a provider of robotic computing solutions.

Series AMay 28, 2025
Amount Raised: $100,000,000
Differential Robotics

Hangzhou, Zhejiang, China

Differential Robotics is a robotics company providing research, design, and development of aerial robots and intelligent autonomous drones.

DronesMechanical EngineeringRobotics
AngelMay 14, 2025
LTZ Therapeutics

San Francisco, California, United States

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

BiotechnologyHealth CareMedical
Series AApr 24, 2025
Amount Raised: $40,000,000
BOTINKIT

Shenzhen, Guangdong, China

BOTINKIT is creating the first robot-based digital food ecosystem in the world.

Big DataRobotics
Series BApr 3, 2025
Zhongke Guosheng

Hangzhou, Zhejiang, China

Zhongke Guosheng is research and development firm that designs and manufactures furan-based bio-based materials.

Advanced MaterialsBiotechnologyChemicalChemical EngineeringManufacturing
Series AMar 5, 2025
Amount Raised: $27,543,657
Xinyanyi Code

Shenzhen, Guangdong, China

Xinyanyi Code is an artificial intelligence programming application service provider.

Series AJan 10, 2025
StepStar

Xuhui, Shanghai, China

StepStar is an artificial intelligence company that is dedicated to advancing toward artificial general intelligence (AGI).

Artificial Intelligence (AI)Generative AINatural Language Processing
Series BDec 23, 2024
Amount Raised: $3,000,000
Omi AI

San Francisco, California, United States

Open-source AI companion

Pre SeedAug 2, 2024
Amount Raised: $700,000
ReviR Therapeutics

Brisbane, California, United States

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Alternative MedicineBiotechnologyGeneticsTherapeutics
Series AJul 26, 2024
Amount Raised: $30,000,000
AGORAB2B

São Paulo, Sao Paulo, Brazil

POWERFUL platform for B2B e-commerce and sourcing

B2BE-CommerceE-Commerce PlatformsProcurementSaaS
SeedOct 17, 2023
Amount Raised: $70,000